BMJ editor: Open letter to Roche about oseltamivir trial data
Roche promised in 2009 to release full reports from clinical trials of oseltamivir in response to an investigation by the BMJ and the Cochrane Collaboration. In this open letter to John Bell, regius professor of medicine at Oxford University and a Roche board member, the BMJ’s editor in chief further urges the company to disclose the full data.
Read the full letter here.
Posted on October 29, 2012, in data sharing, drug safety and tagged BMJ, Cochrane Collaboration, data sharing, Fiona Godlee, open science, oseltamivir, publication bias, Roche, Tamiflu. Bookmark the permalink. Leave a comment.